Tela Bio, Inc. (TELA) — 10-Q Filings

10-Q Filings (6)

• TELA Bio's Q3 Revenue Rises, But Losses Mount Amid Cash Burn — Nov 14, 2025 Risk: high
  TELA Bio, Inc. reported revenue of $20.689 million for the three months ended September 30, 2025, an increase from $18.957 million in the same period of 2024. F
• TELA Bio Revenue Jumps 28% Amid Narrowing Losses — Aug 11, 2025 Risk: medium
  TELA Bio, Inc. reported a significant increase in revenue for the three months ended June 30, 2025, reaching $19.5 million, up from $15.2 million in the prior y
• TELA Bio Files Q1 2025 10-Q Financial Update — May 8, 2025 Risk: low
  TELA Bio, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information including retained earnings, additional paid-in cap
• TELA Bio Reports Q3 2024 Financials, Notes Key Events — Nov 8, 2024 Risk: medium
  TELA Bio, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial position, including details on retained earnings, add
• TELA Bio Q2 2024 Financials Filed — Aug 13, 2024 Risk: low
  TELA Bio, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial position, including retained earnings, additional
• TELA Bio, Inc. Files 10-Q for Period Ending March 31, 2024 — May 10, 2024 Risk:
  TELA Bio, Inc. (TELA) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. TELA Bio, Inc. filed a 10-Q report for the period ending March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX